L

Latigo Biotherapeutics, Inc.

17 employees

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.

Basic info

Industry

biotechnology research

Date founded

2018

Funding rounds raised

Total raised

$15M

from 1 investors over 1 rounds

L

Latigo Biotherapeutics, Inc. raised $15M on August 21, 2020

Investors: Corner Ventures

FAQ